Featured Research

from universities, journals, and other organizations

A Few Squares Of Dark Chocolate A Day May Stave Off Artery Hardening In Smokers

Date:
January 3, 2006
Source:
BMJ Specialty Journals
Summary:
Dark chocolate may stave off artery hardening in smokers, and a few squares every day could potentially cut the risk of serious heart disease, finds a small study in Heart.

Dark chocolate may stave off artery hardening in smokers, and a few squares every day could potentially cut the risk of serious heart disease, finds a small study in Heart.

Researchers compared the effects of dark (74% cocoa solids) and white chocolate on the smoothness of arterial blood flow in 20 male smokers.

In smokers the activity of both endothelial cells, which line the artery walls, and platelets, which are involved in the formation of blood clots, are continuously disrupted, making the arteries susceptible to the narrowing and hardening characteristic of coronary artery disease.

Before eating 40 g of chocolate (about 2 oz), smokers were first asked to abstain from other foods rich in antioxidants, such as onions, apples, cabbage, and cocoa products for 24 hours.

After two hours, ultrasound scans revealed that dark chocolate significantly improved the smoothness of arterial flow, an effect which lasted for eight hours. Blood sample analysis also showed that dark chocolate almost halved platelet activity. Antioxidant levels rose sharply after two hours.

White chocolate had no effect on endothelial cells, platelets, or antioxidant levels.

Dark chocolate has more antioxidants per gram than other foods laden with the substances, such as red wine, green tea, and berry fruits, say the authors, who suggest that the beneficial effects of dark chocolate lie in its antioxidant content.

"...Only a small daily treat of dark chocolate may substantially increase the amount of antioxidant intake and beneficially affect vascular health," conclude the authors.

###

Citation: Dark chocolate improves endothelial and platelet function Heart 2006; 92: 119-20




Story Source:

The above story is based on materials provided by BMJ Specialty Journals. Note: Materials may be edited for content and length.


Cite This Page:

BMJ Specialty Journals. "A Few Squares Of Dark Chocolate A Day May Stave Off Artery Hardening In Smokers." ScienceDaily. ScienceDaily, 3 January 2006. <www.sciencedaily.com/releases/2006/01/060102123255.htm>.
BMJ Specialty Journals. (2006, January 3). A Few Squares Of Dark Chocolate A Day May Stave Off Artery Hardening In Smokers. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/01/060102123255.htm
BMJ Specialty Journals. "A Few Squares Of Dark Chocolate A Day May Stave Off Artery Hardening In Smokers." ScienceDaily. www.sciencedaily.com/releases/2006/01/060102123255.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins